---  
layout: startup_page  
title: "Areteia Therapeutics"  
id: "areteiatx.com"  
permalink: "/areteiatherapeuticsareteiatx.com02132024/"  
website: "https://areteiatx.com"  
funding_round: "Series A"  
funding_amount: "$425M"  
investors: "Viking Global Investors, Marshall Wace, Bain Capital Life Sciences, Access Biotechnology, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, Population Health Partners"  
about: "Areteia Therapeutics is a clinical-stage biotechnology company focused on developing novel inflammation and immunology therapies for respiratory diseases. Their lead drug candidate, dexpramipexole, is an oral eosinophil maturation inhibitor being developed as a potential first-in-class treatment for severe eosinophilic asthma. The company aims to improve patient control over their disease."  
markets: "Biotechnology, Pharmaceuticals, Healthtech"  
hq: "Chapel Hill, North Carolina, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/areteiatx"  
twitter: "https://twitter.com/aristeatx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/areteia-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/501401-44"  

date_display: "13-Feb-2024"  
date: "2024-02-13"

# SEO Optimization  
meta_title: "Areteia Therapeutics - Series A Funding ($425M)"  
meta_description: "Areteia Therapeutics, Areteia Therapeutics is a clinical-stage biotechnology company focused on developing novel inflammation and immunology therapies for respiratory disea..."  
meta_keywords: "Areteia Therapeutics, Biotechnology, Pharmaceuticals, Healthtech, Series A funding"  
canonical_url: "https://startup.projectstartups.com/areteiatherapeuticsareteiatx.com02132024/"  
---